Arkolith/Insider Trading/ZIVO/Form 4

Strome Mark E

10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Dec 31, 2024
Net Buying
Open-Market Buys
$1.5M
Open-Market Sells
$0
Net Open-Market Flow
$1.5M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2024Buy(P)75K$20.19$1.5M399K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 26, 2024Buy(P)8K—$044K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-113655) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML